Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immune Design Corp. | 25,000 | reported | 07 Jan 2015 | tx 1+25,000 |
| Nivalis Therapeutics, Inc. | 0 | reported | 20 May 2024 | tx 72+1,077,039−1,077,039 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 31,200 | — | |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 26,761 | — | |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 108,999 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 112,500 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 836 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 1,214 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 143 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 137 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 78,000 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 112,945 | — | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 398 | 5.02 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 18,286 | 3.23 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 164 | 11.31 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 857 | 6.51 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 1 | 7.55 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 7,055 | 13.20 USD | |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 18,286 | 0.00 USD | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 398 | 0.00 USD | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 1 | 0.00 USD | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 857 | 0.00 USD | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 164 | 0.00 USD | deriv |
| 07 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 7,055 | 0.00 USD | deriv |
| 26 Jan 2024 | SALE | Nivalis Therapeutics, Inc. | 44,000 | 25.00 USD | |
| 26 Jan 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 44,000 | 11.31 USD | |
| 26 Jan 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 73,764 | 6.51 USD |